Clinical trial
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
NCT00099749 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- Not reported
- Enrollment
- 255
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantation